Ningbo Xu

8PUBLICATIONS
18CO-AUTHORS
Traditional Chinese medicine and treatmentsAerodynamics (excl. hypersonic aerodynamics)Predictive and prognostic markersInfant and child healthNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 29, 2025
Retraction Note: Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy.

Yixin Zhang, Ningbo Xu, Yan Ding

|Jul 19, 2023
Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.

Xionghui Chen, Xuying He, Feng Xu

|Dec 24, 2022
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.

Wenhui Tang, Ningbo Xu, Jian Zhou

|May 23, 2020
LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma.

Boyang Liu, Jian Zhou, Chenyang Wang

|Feb 06, 2019
Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy.

Yixin Zhang, Ningbo Xu, Yan Ding

|Nov 17, 2018
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma.

Ningbo Xu, Boyang Liu, Changlin Lian

Pageof 2

Frequent Collaborators

5 joint publications

John H Zhang

2 joint publications

Jiping Tang

2 joint publications

Boyang Liu

1 joint publications

Nathanael Matei